Free Trial

Nyxoah (NYXH) Competitors

$8.50
+0.17 (+2.04%)
(As of 03:59 PM ET)

NYXH vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW

Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.

Nyxoah vs.

Nyxoah (NASDAQ:NYXH) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk.

In the previous week, Nyxoah had 16 more articles in the media than 180 Life Sciences. MarketBeat recorded 16 mentions for Nyxoah and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 beat Nyxoah's score of -0.08 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Nyxoah Neutral
180 Life Sciences Neutral

Nyxoah received 30 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
NyxoahOutperform Votes
30
66.67%
Underperform Votes
15
33.33%
180 Life SciencesN/AN/A

180 Life Sciences has a net margin of 0.00% compared to Nyxoah's net margin of -843.49%. 180 Life Sciences' return on equity of 0.00% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-843.49% -42.14% -33.55%
180 Life Sciences N/A N/A N/A

180 Life Sciences has lower revenue, but higher earnings than Nyxoah.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$4.70MN/A-$46.77M-$1.64-5.12
180 Life SciencesN/AN/AN/AN/AN/A

Nyxoah presently has a consensus target price of $19.40, suggesting a potential upside of 130.95%. Given Nyxoah's higher possible upside, equities analysts plainly believe Nyxoah is more favorable than 180 Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Nyxoah beats 180 Life Sciences on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NYXH vs. The Competition

MetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.86B$5.00B$8.05B
Dividend YieldN/A2.01%2.81%3.93%
P/E Ratio-5.129.71133.4015.40
Price / SalesN/A69.522,452.2675.54
Price / CashN/A47.6935.9531.61
Price / Book1.655.015.434.60
Net Income-$46.77M$4.50M$104.34M$213.88M
7 Day Performance-17.00%-2.75%-1.47%-1.28%
1 Month Performance-21.50%0.04%2.64%2.96%
1 Year Performance21.04%16.62%3.36%7.62%

Nyxoah Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-57.4%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.08
-28.6%
N/AN/A$0.00$253,573.000.002Positive News
Gap Down
ACONW
Aclarion
0 of 5 stars
$0.03
-25.5%
N/A-45.2%$0.00$75,404.000.004News Coverage
AIMDW
Ainos
0 of 5 stars
$0.04
-33.0%
N/AN/A$0.00$122,112.000.0046Positive News
Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.23
flat
N/A-33.0%$0.00N/A0.00121Gap Down
ALVOW
Alvotech
0 of 5 stars
$2.89
-11.1%
N/A+177.4%$0.00$91.43M0.00999Positive News
Gap Down
ALVO
Alvotech
0.0506 of 5 stars
$13.35
+0.5%
$12.67
-5.1%
+66.6%$0.00$93.38M-5.491,026Earnings Report
Analyst Forecast
AONCW
American Oncology Network
0 of 5 stars
$0.19
flat
N/AN/A$0.00$1.28B0.001,525Positive News
AONC
American Oncology Network
0 of 5 stars
$3.47
+0.3%
N/AN/A$0.00$1.28B0.001,525
APLMW
Apollomics
0 of 5 stars
$0.02
flat
N/A-82.8%$0.00N/A0.0059Positive News

Related Companies and Tools

This page (NASDAQ:NYXH) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners